Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • EUROPE BIOSURGERY MARKET FORECAST 2021-2028

EUROPE BIOSURGERY MARKET FORECAST 2021-2028

The Europe biosurgery market is estimated to grow with a CAGR of 6.16% over the forecast period of 2021 to 2028. The increasing adoption of new and advanced surgical products, the growing burden of chronic conditions likely to cause physical disability, and the rising number of surgeries are among the key factors influencing the region’s market growth.

EUROPE BIOSURGERY MARKET FORECAST 2021-2028

Europe Market by Product ( Hemostatic Agents, Bone-graft Substitutes ( Synthetic Graft Extenders, Demineralized Bone Matrix, Bone Morphogenetic Proteins, Cell-based Matrices ) Surgical Sealing Agents ( Natural, Synthetic ) Soft-tissue Management ( Synthetic Mesh/patch, Natural Mesh/patch ) Anti-adhesive Agents, Staple Line Reinforcement ) Market by Source Type ( Natural, Synthetic ) Market by Application ( Orthopedic Surgery, Cardio and Thoracic Surgery, Neuro and Spine Surgery, General Surgery, Other Applications ) by Geography.

Request free sample

The Europe biosurgery market is estimated to grow with a CAGR of 6.16% over the forecast period of 2021 to 2028. The increasing adoption of new and advanced surgical products, the growing burden of chronic conditions likely to cause physical disability, and the rising number of surgeries are among the key factors influencing the region’s market growth.europe-biosurgery-market

To learn more about this report, request a free sample copy

The Europe biosurgery market growth evaluation constitutes the assessment of Poland, Italy, Germany, Belgium, France, the United Kingdom, Russia, and the rest of Europe. The United Kingdom’s market growth is fuelled by the high incidence of cardiovascular conditions and diabetes, the increased focus of key players on research and development endeavors, and technological advancements. The high incidence rates of diabetes and other chronic conditions are attributed to sedentary lifestyles prevalent across the country, resulting in wound-related complications during surgery. Therefore, the demand for biosurgery products witnesses a growing trend in the United Kingdom.

On the other hand, France is well-known for its excellent healthcare services. Hence, owing to this aspect, the nation is one of the top preferences for patients seeking world-class medical treatment related to biosurgeries. As per the Fondation de France, obesity is a public health concern in France, with around 10% of the population being obese and 20% of children identified as overweight. Besides, 1 in 5 people was estimated to be obese in 2020. This has facilitated an increase in the number of surgeries performed in France, thereby bolstering the overall market demand. Hence, the drivers mentioned above are set to propel the biosurgery market growth in Europe over the forecasting years.

Sanofi SA, headquartered in France, is a pharmaceutical group that manufactures, develops, and markets healthcare products. It provides a diverse range of products associated with multiple sclerosis, rare diseases, cardiovascular diseases, diabetes, and oncology. The company also offers consumer healthcare products, prescription products, and vaccines.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • PREVALENCE OF GERIATRIC POPULATION
        • ADVANCEMENTS IN TECHNOLOGY
        • INCIDENCE OF MUSCULOSKELETAL DISORDERS
        • SURGE IN RESEARCH AND DEVELOPMENT
      • KEY RESTRAINTS
        • HIGH COST OF SURGERIES
        • RISK ASSOCIATED WITH THE IMMUNE RESPONSE
        • GROWING POPULARITY OF MINIMALLY INVASIVE PROCEDURES
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON BIOSURGERY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES MODEL
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRY
        • INDUSTRY RIVALRY
      • KEY BUYING CRITERIA
      • KEY INSIGHTS
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY PRODUCT
      • HEMOSTATIC AGENTS
      • BONE-GRAFT SUBSTITUTES
        • SYNTHETIC GRAFT EXTENDERS
        • DEMINERALIZED BONE MATRIX
        • BONE MORPHOGENETIC PROTEINS
        • CELL-BASED MATRICES
      • SURGICAL SEALING AGENTS
        • NATURAL
        • SYNTHETIC
      • SOFT-TISSUE MANAGEMENT
        • SYNTHETIC MESH/PATCH
        • NATURAL MESH/PATCH
      • ANTI-ADHESIVE AGENTS
      • STAPLE LINE REINFORCEMENT
    3. MARKET BY SOURCE TYPE
      • NATURAL
      • SYNTHETIC
    4. MARKET BY APPLICATION
      • ORTHOPEDIC SURGERY
      • CARDIO AND THORACIC SURGERY
      • NEURO AND SPINE SURGERY
      • GENERAL SURGERY
      • OTHER APPLICATIONS
    5. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • UNITED KINGDOM
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • BAXTER INTERNATIONAL INC
        • B BRAUN MELSUNGEN AG
        • BECTON, DICKINSON AND COMPANY (C R BARD)
        • BETATECH MEDICAL
        • CSL LIMITED
        • CRYOLIFE INC
        • ETHICON INC (JOHNSON & JOHNSON)
        • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
        • MEDTRONIC PLC
        • RTI SURGICAL
        • SANOFI
        • SMITH & NEPHEW PLC
        • STRYKER CORPORATION
        • WRIGHT MEDICAL GROUP NV
        • ZIMMER BIOMET HOLDINGS INC

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – BIOSURGERY

    TABLE 2: EUROPE BIOSURGERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: EUROPE BIOSURGERY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028, (IN $ MILLION)

    TABLE 4: EUROPE BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: EUROPE BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: EUROPE SURGICAL SEALING AGENTS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: EUROPE SURGICAL SEALING AGENTS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: EUROPE SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: EUROPE SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: EUROPE BIOSURGERY MARKET, BY SOURCE TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: EUROPE BIOSURGERY MARKET, BY SOURCE TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: EUROPE BIOSURGERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: EUROPE BIOSURGERY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: EUROPE BIOSURGERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: EUROPE BIOSURGERY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: LEADING PLAYERS OPERATING IN EUROPE BIOSURGERY MARKET

    TABLE 17: LIST OF MERGERS & ACQUISITIONS

    TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 20: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES 

    FIGURE LIST

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: EUROPE BIOSURGERY MARKET, BY PRODUCT, IN 2020

    FIGURE 6: EUROPE BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)

    FIGURE 7: EUROPE BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)

    FIGURE 8: EUROPE BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION)

    FIGURE 9: EUROPE BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION)

    FIGURE 10: EUROPE BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION)

    FIGURE 11: EUROPE BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)

    FIGURE 12: EUROPE BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)

    FIGURE 13: EUROPE SURGICAL SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)

    FIGURE 14: EUROPE SURGICAL SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)

    FIGURE 15: EUROPE BIOSURGERY MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)

    FIGURE 16: EUROPE SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION)

    FIGURE 17: EUROPE SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)

    FIGURE 18: EUROPE BIOSURGERY MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)

    FIGURE 19: EUROPE BIOSURGERY MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)

    FIGURE 20: EUROPE BIOSURGERY MARKET, BY SOURCE TYPE, IN 2020

    FIGURE 21: EUROPE BIOSURGERY MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)

    FIGURE 22: EUROPE BIOSURGERY MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)

    FIGURE 23: EUROPE BIOSURGERY MARKET, BY APPLICATION, IN 2020

    FIGURE 24: EUROPE BIOSURGERY MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)

    FIGURE 25: EUROPE BIOSURGERY MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)

    FIGURE 26: EUROPE BIOSURGERY MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)

    FIGURE 27: EUROPE BIOSURGERY MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)

    FIGURE 28: EUROPE BIOSURGERY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 29: EUROPE BIOSURGERY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 30: GERMANY BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 31: UNITED KINGDOM BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 32: FRANCE BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 33: ITALY BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 34: RUSSIA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 35: BELGIUM BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 36: POLAND BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 37: REST OF EUROPE BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • UNITED KINGDOM
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY PRODUCT
      • HEMOSTATIC AGENTS
      • BONE-GRAFT SUBSTITUTES
        • SYNTHETIC GRAFT EXTENDERS
        • DEMINERALIZED BONE MATRIX
        • BONE MORPHOGENETIC PROTEINS
        • CELL-BASED MATRICES
      • SURGICAL SEALING AGENTS
        • NATURAL
        • SYNTHETIC
      • SOFT-TISSUE MANAGEMENT
        • SYNTHETIC MESH/PATCH
        • NATURAL MESH/PATCH
      • ANTI-ADHESIVE AGENTS
      • STAPLE LINE REINFORCEMENT
    2. MARKET BY SOURCE TYPE
      • NATURAL
      • SYNTHETIC
    3. MARKET BY APPLICATION
      • ORTHOPEDIC SURGERY
      • CARDIO AND THORACIC SURGERY
      • NEURO AND SPINE SURGERY
      • GENERAL SURGERY
      • OTHER APPLICATIONS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now